Japan's short-term survey index of large-scale manufacturing industry in December reported 14, with an estimated 13.The "unlimited price" for a single plot of high-quality land in Beijing has gradually started. After only half a month, Beijing once again auctioned a single plot of land exceeding 10 billion yuan. On December 12, the Wanquan Temple plot outside the southwest second ring road of Fengtai, Beijing was acquired by Zhonghai for 11.054 billion yuan. So far, the total number of land auctions in Beijing has reached 40 this year, and the total amount of land transfer fees has exceeded 150 billion yuan. It is worth mentioning that the future commercial housing sales of this plot are not limited. The industry unanimously believes that the cancellation of the double limit of land price and house price shows that the one with the highest price is becoming a new trend of high-quality land auction in Beijing, and on the other hand, it is a powerful performance of returning the property market to the market. (beijing business today)The yen once fell to 152.74 against the US dollar, and the trend fluctuated after the release of the Bank of Japan's short-term survey. After the release of the Bank of Japan's short-term survey, the yen initially rose slightly, but then weakened. The yen once fell 0.1% against the US dollar to 152.74. The 10-year Japanese government bond futures rose 4 points to 142.49.
Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.The "unlimited price" for a single plot of high-quality land in Beijing has gradually started. After only half a month, Beijing once again auctioned a single plot of land exceeding 10 billion yuan. On December 12, the Wanquan Temple plot outside the southwest second ring road of Fengtai, Beijing was acquired by Zhonghai for 11.054 billion yuan. So far, the total number of land auctions in Beijing has reached 40 this year, and the total amount of land transfer fees has exceeded 150 billion yuan. It is worth mentioning that the future commercial housing sales of this plot are not limited. The industry unanimously believes that the cancellation of the double limit of land price and house price shows that the one with the highest price is becoming a new trend of high-quality land auction in Beijing, and on the other hand, it is a powerful performance of returning the property market to the market. (beijing business today)South Korea will take additional market stabilization measures when necessary.
Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.People's Daily: Ensure that artificial intelligence is always a "friend". At present, the ability of artificial intelligence is comparable to that of human brain in many aspects, but it cannot accurately distinguish right from wrong in terms of value. This means that it is necessary to strengthen the supervision and regulation of artificial intelligence from many aspects. In recent years, many countries, including China, have introduced artificial intelligence development plans, management methods and supervision principles, precisely to ensure that technology truly serves people and benefits society. No matter how far artificial intelligence develops, it all comes from human design and is an extension of human wisdom. Artificial intelligence is doing more and more work and becoming more and more intelligent. We must take precautions to ensure that it is always a "friend".CITIC Securities: Relevant central state-owned enterprises engaged in business and equity cooperation with Huawei are expected to enjoy Huawei's empowerment. CITIC Securities pointed out that at the moment when the four sectors of intelligent selection are gathering together and the HI model is fully expanded, we believe that the investment core of Huawei's OEM is "change and invariance", that is, business model and partner iteration, but the top-level design of "not building cars, helping car companies build good cars" and the commercial appeal of maximizing sales and profits are not avoided. In addition, in the stage of deep cooperation with Huawei, the organizational structure and corporate governance of partners have been greatly improved. Similarly, we believe that relevant central state-owned enterprises engaged in business and equity cooperation with Huawei are expected to enjoy Huawei's empowerment, and Huawei will help the reform of state-owned enterprises.
Strategy guide
Strategy guide 12-14
Strategy guide
12-14